Matches in Library of Congress for { <http://lccn.loc.gov/2007033206> ?p ?o. }
Showing items 1 to 24 of
24
with 100 items per page.
- 2007033206 contributor B10788720.
- 2007033206 created "c2007.".
- 2007033206 date "2007".
- 2007033206 date "c2007.".
- 2007033206 dateCopyrighted "c2007.".
- 2007033206 description "Kept up-to-date by supplements.".
- 2007033206 description "Statutory and regulatory controls for drug development -- Key federal agencies regulating pharmaceuticals -- Federal regulation of advertising, promotion, and distribution practices -- Potential liability for drug companies, health care providers and insurers : off-label prescribing and internet advertising -- Federal regulation of clinical research -- Avoiding fraud and abuse penalties and sanctions -- Regulation of privacy under HIPAA and other privacy laws -- Federal sentencing guidelines and compliance measures -- The FDA approval process for new drugs -- State regulatory schemes for pharmaceuticals and related issues -- Antitrust and intellectual law issues for pharmaceutical companies -- Securities law issues and disclosure considerations for pharmaceutical companies.".
- 2007033206 extent "xlvi, 853 p. ;".
- 2007033206 identifier "9781570185762 (alk. paper)".
- 2007033206 identifier 2007033206.html.
- 2007033206 issued "2007".
- 2007033206 issued "c2007.".
- 2007033206 language "eng".
- 2007033206 publisher "Arlington, Va : Bureau of National Affairs,".
- 2007033206 spatial "United States.".
- 2007033206 subject "344.7304/16 22".
- 2007033206 subject "Drug development United States.".
- 2007033206 subject "Drugs Law and legislation United States.".
- 2007033206 subject "KF2915.P4 P495 2007".
- 2007033206 subject "Pharmaceutical industry United States.".
- 2007033206 subject "Pharmacy Law and legislation United States.".
- 2007033206 tableOfContents "Statutory and regulatory controls for drug development -- Key federal agencies regulating pharmaceuticals -- Federal regulation of advertising, promotion, and distribution practices -- Potential liability for drug companies, health care providers and insurers : off-label prescribing and internet advertising -- Federal regulation of clinical research -- Avoiding fraud and abuse penalties and sanctions -- Regulation of privacy under HIPAA and other privacy laws -- Federal sentencing guidelines and compliance measures -- The FDA approval process for new drugs -- State regulatory schemes for pharmaceuticals and related issues -- Antitrust and intellectual law issues for pharmaceutical companies -- Securities law issues and disclosure considerations for pharmaceutical companies.".
- 2007033206 title "Pharmaceutical law : regulation of research, development, and marketing / editor-in-chief, Michael E. Clark.".
- 2007033206 type "text".